Literature DB >> 26222076

Mechanisms of Drug Resistance Related to the Microenvironment of Solid Tumors and Possible Strategies to Inhibit Them.

Qian Tan1, Jasdeep K Saggar, Man Yu, Marina Wang, Ian F Tannock.   

Abstract

Drug resistance can occur at the individual cellular level or as a result of properties of the tumor microenvironment. The convoluted vasculature within tumors results in robustly proliferating well-nourished cells located proximal to functional blood vessels and regions of slowly proliferating (often hypoxic) cells located distal to functional blood vessels. Irregular blood flow and large distances between functional blood vessels in solid tumors lead to poor drug distribution within them such that cells distal from functional blood vessels are exposed to ineffective concentrations of drug, resulting in therapeutic resistance. Strategies to improve or complement the distribution of anticancer drugs within tumors hold promise for increasing antitumor effects without corresponding increases in normal tissue toxicity. In particular, use of hypoxia-targeted agents and modulation of autophagy have shown promising results in enhancing the distribution of drug activity within solid tumors and hence antitumor efficacy. In this review, we describe causes of resistance to chemotherapy that relate to the microenvironment of solid tumors and the potential to improve antitumor effects by countering such mechanisms of resistance.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26222076     DOI: 10.1097/PPO.0000000000000131

Source DB:  PubMed          Journal:  Cancer J        ISSN: 1528-9117            Impact factor:   3.360


  16 in total

1.  Hypoxia induces universal but differential drug resistance and impairs anticancer mechanisms of 5-fluorouracil in hepatoma cells.

Authors:  Jing-Qiu Li; Xian Wu; Lu Gan; Xiang-Liang Yang; Ze-Hong Miao
Journal:  Acta Pharmacol Sin       Date:  2017-07-10       Impact factor: 6.150

2.  Hypoxia Promotes Resistance to EGFR Inhibition in NSCLC Cells via the Histone Demethylases, LSD1 and PLU-1.

Authors:  Yuhong Lu; Yanfeng Liu; Sebastian Oeck; Peter M Glazer
Journal:  Mol Cancer Res       Date:  2018-06-22       Impact factor: 5.852

Review 3.  Adaptive mechanisms of resistance to anti-neoplastic agents.

Authors:  Bibiana I Ferreira; Maria K Lie; Agnete S T Engelsen; Susana Machado; Wolfgang Link; James B Lorens
Journal:  Medchemcomm       Date:  2016-10-21       Impact factor: 3.597

Review 4.  Targeting Tumor Adaption to Chronic Hypoxia: Implications for Drug Resistance, and How It Can Be Overcome.

Authors:  Jae-Young Kim; Joo-Yong Lee
Journal:  Int J Mol Sci       Date:  2017-08-25       Impact factor: 5.923

5.  Focused Ultrasound Hyperthermia Mediated Drug Delivery Using Thermosensitive Liposomes and Visualized With in vivo Two-Photon Microscopy.

Authors:  Marc A Santos; David E Goertz; Kullervo Hynynen
Journal:  Theranostics       Date:  2017-07-07       Impact factor: 11.556

Review 6.  Targeting oncogenic vulnerabilities in triple negative breast cancer: biological bases and ongoing clinical studies.

Authors:  Alberto Ocana; Atanasio Pandiella
Journal:  Oncotarget       Date:  2017-03-28

Review 7.  Molecular mechanisms of hypoxia in cancer.

Authors:  Amarnath Challapalli; Laurence Carroll; Eric O Aboagye
Journal:  Clin Transl Imaging       Date:  2017-05-11

8.  Hypoxia Induces Resistance to EGFR Inhibitors in Lung Cancer Cells via Upregulation of FGFR1 and the MAPK Pathway.

Authors:  Yuhong Lu; Yanfeng Liu; Sebastian Oeck; Gary J Zhang; Alexander Schramm; Peter M Glazer
Journal:  Cancer Res       Date:  2020-09-01       Impact factor: 12.701

9.  Theranostic Role of 32P-ATP as Radiopharmaceutical for the Induction of Massive Cell Death within Avascular Tumor Core.

Authors:  Mirco Galiè; Federico Boschi; Ilaria Scambi; Flavia Merigo; Pasquina Marzola; Luisa Altabella; Umberto Lavagnolo; Andrea Sbarbati; Antonello E Spinelli
Journal:  Theranostics       Date:  2017-09-30       Impact factor: 11.556

10.  Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients.

Authors:  Haiying Ding; Jiao Sun; Yu Song; Wenxiu Xin; Junfeng Zhu; Like Zhong; Yinbo Chen; Yiwen Zhang; Yinghui Tong; Luo Fang
Journal:  Front Oncol       Date:  2021-06-11       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.